Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Machiavelli10
Very informative post. Thank you!
I have one question in regards to your last statment.
"With the limited financial resources available this is unfortunately likely to require reallocation of positions and identification of several different personnel but in the interests of the shareholders and the company’s development it seems a necessary next step."
What do you actually mean by this. The company has about five staff members
Bret.................CEO
John Tracy.......... Operations Manager
Carol ...............Office personal
Michelle & Tamara..... Lab tech's
I am not sure of others but what are you saying Move Bret from the CEO position to lab rat or John to Shiping receiving?
I feel getting financial resources at this point would not be a problem so why would there be a need to shift?
Andre
March maybe even February if you recall there was a message on the website stating that the Battelle paper was accepted in Nov. and the paper was published in December.
nmbr1
You make some very good points but really this is happening everyday in the markets. Retail investors are basicly chum in the water to the sharks with large pools of money to work with.
Looking at Nanologix specificly like you said for the last 2-3 years trading at $0.30-$0.50, for the most part, while the company is refining the product and gearing towards approval and now that the company has reached that point and have started sales the pps drops 50% from the midpoint of the range!?!?!? This does not pass the sniff test. Unhappy longs selling? Maybe 1% to 2% maximum shares and I feel that is generous. I know Regularguy from the other board likes to look at the market cap in relations to the EPS and that is fine to get you in the ball park but the market for the most part is forward looking and to think that 6 months to a year from now that Nanologix would be worth 24 million is simply rediculous! Nanologix could gross that much by taking less than 3-1/2% of just the petri dish market alone with a far superior product selling for less or equal to what is in the market now. That is not even including monies to be gotten from BNP/BNF.
To totally dimiss the points that you are making would not be wise to an investor not that you or anybody, for the most part, can stop this minipulation but to know that it is occuring (possibly) is important when buying and sell this stock. Tin foil hat some may say but to deny it will make it easier to succumb to it.
Whats occuring with Nanologix as far as it products and it entrance into the markets and it stock price steady decline is illogical. I feel, as others do, that this stock is over sold at the moment and that we should see the pps channeling up very shortly. IMHO
Andre
Leroy
After rereading my post it may have been a little misleading.
this was the quote from his post (PDE)
"Ok, since it's been reported 'essentially ALL' of Nano's sales to this point have been to our favorite 3rd party, mostly for use on government projects, what's the changes that the government COULD ink a $1/2 million dollar contract? Seems they routinely sing contracts for billions... NOT saying it's going to happen, just personally thinking there is some huge potential per the Battelle paper, and 4 months of shelf life test ANNOUNCED YESTERDAY!"
Andre
Jonny
It is a good thought but they are expensive personally I feel that the K Street lobbiest are destoying this country but that is another argument for another day.
Battelle might not give them the total bang for the buck but they will definatly give them the boost to get things started. I wouldn't be surprised to see another large order from them or perhaps a contract kind of like what Petro was hinting at (1/2 million dollars contract).Once the money starts to flow than they can add a sales team before you spent money on lobbiest IMO.
Andre
Packaging update
http://nanologix.com/news/nnlx-packaging-1-11-2013.pdf
Major 3rd-Party R&D Lab Long-Term
Room Temperature Storage
evaluation contrasting NanoLogix
Tryptic Soy Agar (TSA) packaged
in proprietary Inert Gas-Charged
Vacuum Flatpack against
Brand X TSA packaged in industrystandard
packaging.
• For NanoLogix agar:
• NanoLogix TSA plates in proprietary packaging have exceeded one year
shelf life in cold storage with no degradation of quality
• In internal NanoLogix lab tests conducted to test RT life, TSA plates stored
at room temperature have currently passed nine months of effectiveness
with no degradation in quality.
• In RT tests ongoing at a major 3rd party Research and Development
facility, NanoLogix TSA plates have passed a four-month milestone with no
loss in efficacy for Anthrax detection.
• The potential impact on the petri market is vast, with approximately
two million petri plates used each day in the US, and many more used
internationally, any storage advancement that extends the useable
lifespan of testing agar by multiples of what has been previously available
will have a major market impact.
• NanoLogix packs both its Petri plates and BNP culture-based plates in its
proprietary patent-pending inert-gas-charged vacuum flatpacks.
• NanoLogix anticipates room temperature life of its basic TSA media to
potentially exceed one year.
• The following shows the results from the 3rd party facility.
We as a country are very vulnerable a lot of people don't realize with the slow growth of the bacteria and Doctors not really expecting or looking for TB we could easily have large outbreaks. After reading the article you could see with the difficulty of getting the proper medicine and the cost involved we could have serious problems!
from the article
". A recent study led by a CDC researcher found that the average total direct cost to treat a patient in the U.S. with multidrug-resistant TB is $131,000."
andre
nmbrs
I was curious about the alexa ranking today to see if the paper publication (which is now linked on the web site)will have any effect on the ranking.
today is 352,861
9/9/12 was 52,472
I clinked on the reputation # which is 46 and it tells you how many sites have a link to the Nanologix website and lists them. I went to the list and skimed through it and found this site
http://www.sokolovelaw.com/blog/2010/06/01/bacteria-screening-and-treatment-to-prevent-birth-injuries
This law firm is always on TV in my area and it caught my eye. I know Parents and other,and maybe you also, have mentioned that once lawyers find out about faster tests law suits will ensue which inturn will speed up implementation. Where there is money to be made I am sure there will be more law firms trolling for new clients!!!
Andre
Nice post!
you stated
"Moving the system to the next level of aggressive marketing necessitates acquisition of such a person in that defined role."
Nanologix has a plan in place or so it seems. This is from a post on another board in which a poster (PDE) spoke with the CEO and he (Bret)stated
"We have had multiple major corporations approach NanoLogix regarding distribution of our products, but the company is not ready to announce the plan until the independent peer-reviewed papers are published."
http://finance.yahoo.com/mbview/threadview/?&bn=2e8f6abb-7185-32da-8cf1-2a5bc5d0bae7&tid=1354228758025-abd91d30-54ec-49f5-975d-5f22c8c2c8f9
So moving to the next level may not necessitate a person filling that role but a corporation instead which would be vastly better. IMHO
Andre
omicsonline.org/1948-5948/pdfdownload.php?download=JMBT-04-147.pdf&&aid=10157
gosox12
Just for the record I am no expert I am just sharing the information that I have come across take it for what it is worth.
The following is an exerpt from an book (on line) that was given to me by another stock holder. The book is on the priciples of developing drugs,diagnostics, and devices.
<<< 510(k) submission type and content
There is no specific 510(k) form but instead a format for the submission is described
in 21 CFR 807 and in multiple guidance documents by the FDA. The term 510(k)
refers to the original section of the CFR that described the process of clearing a
device that demonstrates substantial equivalence to a device already on the market
before 1976 or another 510(k) cleared device on the market currently (a predicate
device). Since the 510(k) process is much shorter than the PMA route, most
companies try to qualify their devices into the 510(k) pathway. However, as this
process may not generate adequate clinical data to satisfy insurance companies or
other payers, often manufacturers will benefit by performing more extensive clinical
studies to show the specific clinical benefits of the new device or technology (see
Chapter 7 for detailed discussion). To identify a list of 510(k) cleared devices that
might be predicate devices, see Section 5.5.3.>>>
So they did the study using the petri dish as the SE device the FDA Ok'd it. Now they are doing the trials to satisfy the Insurance companies or other players i.e. companies that want to use the products also the FDA wants to make sure that the third party (in this case TMC) did its work properly and if they did not it would show up in the trials.
I am guessing that the hospitals that will be doing these trials will be buying kits during the processso that is a plus and if the outcome is good they will continue to do so. I don't this for sure however.
Andre
My response to that post other there but it won't allow me to post it.
Sunlover
The way I understand it is as follows
A study is done and the findings of the study are used to apply for FDA approval.
After review of the study information and the application the FDA gave approval in the form of the 510k exemption.
Now a clinical trial is needed to solidfy the fact put forth in the study.
this is an exerpt from the FDA website
"The development of this clinical trial guidance resulted from a concern about the quality of clinical trials submitted to the Agency in support of medical device applications. This concern applied to many critical elements of clinical trial design, conduct, and analysis and was supported by the findings of the Committee for Clinical Review chaired by Dr. Robert Temple, Ann Witt served as co-chair, whose report became publicly available in March 1993. The CDRH recognized the need for a separate guidance document to address these concerns, and to clearly document those elements needed for a well designed, conducted, and analyzed device clinical trial."
So basicly the FDA wants info from third parties to prove that the study was not faked or provided false information. If you want more info go to the FDA website and do some research.
Andre
I think you just like to be argumentative.
“There's no reason to as it's common accounting knowledge that revenue can not be booked until product has been shipped. It's the law under GAAP accounting rules. “
Come down from your ivory tower for a moment. You nor I know for a fact that the revenues that were booked were in fact that particular order it could have been other orders. The company never officially stated that the 12k order was shipped a share holder stated it
“ No, both situations aren't the same and it seems we are talking about two completely different points”
Exactly! You are arguing apples and oranges just to be agumentative and to try and prove you are more inteligent than everybody here.I never claimed to be wise nor inteligent so I will defer to your superior inteligents.
Have a great week everbody! life is too short for this!
Andre
"They shipped in the 3rd quarter just as the financial statement they recently released states."
Please show me where on the financial statement does it state that this specific 12k order was shipped.I see revenue of $63,908
but I did not see anything about this order. I do assume that it is in that number but you will have to show me because I missed that.
" Percentile of total stares outstanding is not the correct way how to measure dillution because naturally the percent of the total will decrease while the total shares out increases even though the actual amount of dillution may be increasing. Therefore in the case of dillution, you always measure the actual amount of dillution rather than the percentage. It's common sense."
I will look at it from your point of view OK lets say company XYZ added 6 mil shares to their existing share count of 600 mil and company ABC added 6 mil shares to their existing share count of 6 mil. In that moment of time my value in company XYZ just got diluted by 1% but the dilution of company ABC just got diluted by 50%. So to you both of the situations are the same?
You spin it any way you want i will look at percentages thank you very much. Common sense?
Well I see your personality shines right through your posts! When I post in the future I will make sure I come and read the posts every single day so as not to make you wait and get upset when I don’t respond!
First let me say I mistakenly said that it was 5 weeks from the 12k order and of coarse it was 5 weeks from the 510k exempt status so any company wanting and ok from the FDA first had five weeks in the quarter to tryout some kits. The 12k unit order started in July and we can assume from what multiple sources have stated that they did ship in the quarter for argument sake. I will give them a couple more quarters to get things rolling.
“I do find the 6,000,000+ share dillution YOY worrisome.”
I don’t have a problem with that it is in line with the last few years of share delution. Hopefully we will see revenue increase shortly to where shares will not be needed to be sold to raise capital.
2009 added 10%
2010 added 6%
2011 added 4%
2012 extrapulated out comes to just over 6%
Numbers are approximate so please don’t critique my math I don’t want to see you get all worked up for nothing.
Andre
"I'd call it a turnaround situation that's taken along time to turn around."
It was 5 weeks from the statment of that 12k order to the end of the quarter. The turn around has started so lets give them a chance to get some traction, perhaps a few quarters under their belt before you poo poo them. It just looks like you want to find something bad to say when good news comes out.
I total agree with you if this where an established company but as it is stated on Nanologix balance sheet "(A DEVELOPMENT STAGE COMPANY)" so this is great news and it tell me that they are transitioning to real company with real products and profit. As far as improving the share price considerably that is yet to be seen but it should help to suport current price. IMHO
Andre
Thanks Bankshot for your post.
Could you help me clearify some of the info?
I understand that $200,000 will go to the 4 Directors (bret, john,jeff, and daniel)and that the offerings could or will last more than a year and that they want to raise $10 million. As far as issuer size and the revenue range of $1 to $1 million exactly does this means? TIA
Andre
POS?
Nanologix is an R&D company making the transition to a commercial entity. Her are some of their acomplisments over the last 9 months.
1) Jan 10,2012 NanoLogix is currently working with a third-party to develop a unique antibody for Listeria for use in pre-screening food packaging, food processing equipment and preparation surfaces and work areas. Tests of the efficacy of the antibody will occur at client facilities.
2) Feb 9,2012 Over the past three years, NanoLogix has benefited from extraordinary relationships with several institutions. These have led to exponentially reduced detection and identification times, plunging from days to hours to – very recently – minutes. This outreach and teamwork is leading to advances that will change the future of diagnostics. That is a huge claim. It is being borne out in tests at this moment.
3) April 24, 2012 A major independent research facility is evaluating the shelf life of petri-based technology sealed in NanoLogix patent-pending “Flat-Pack” vacuum packaging. The results to date demonstrate shelf life of at least one year. The recommended shelf life for standard non-NanoLogix petri-based products packaged in standard packaging is currently three months.
4) May 14, 2012 NanoLogix has reached a milestone with the completion of a 352-patient clinical study focused on rapid detection of Group B Streptococcus in pregnant patients.The information on results of the 352-patient sampling is being submitted to the FDA as a non-invasive diagnostic kit application, with results forwarded to both the Centers for Disease Control and the World Health Organization.
5) June 13, 2012-- NanoLogix (OTC Markets:NNLX) announced today its R&D team in collaboration with University of Texas Health Science Center - Houston (UTHSC-Houston) researchers, are developing a multi-well, microplate reader variant of the company’s BioNanoFilter (BNF) diagnostics for use in large volume laboratory environments. Early analysis of the multi-well plates shows exceptionally fast live-threat results similar to the company’s standard BNF technology.
6) July 5,2012 The company is pleased to announce it has been selected as a vendor by a multi-billion dollar US research and development corporation. The corporation has notified NanoLogix it intends to use approximately 12,000 units of NanoLogix detection technology for a project beginning in July 2012.
7) Aug 15, 2012: NanoLogix is pleased to announce that the company will begin commercial marketing of its BNP (BioNanoPore) and BNF (BioNanoFilter) diagnostic kits under FDA 510K-exempt status.
8) Aug 21, 2012 The results of two independent third-party research studies using NanoLogix technology have been submitted by their respective organizations to major peer-reviewed medical technology journals for publication.
Lets give them some credit we may not be where we want to be but we are getting very close. IMHO
Andre
Ken
$5 is a little unrealistic there is a lot of overhead resistance let see if we can take out the 52 week high ($.60) than lets see about the all time high of $1.48. I think five dollars will be taken out but more things need to fall into place. Of corse I hope I'm wrong and you are right but as long as the pps has a nice steady growth rate i'll be happy.
Andre
numbers
Your logic here makes no sense.
the $61,200 of revenue consists of alot more than agar like utilities , wages, dishes,other ingrediants, etc...
With the information that you have it is almost imposible to figure out posible revenues generated. Now if you knew how many bottles in those cases were being used per week than I could see how you could get a general idea of what weekly revenues were. Useing your 12,ooo kits example only tells you one thing in that particular order generated $61,200 in revenues and that is it you don't even know over what time frame the revs. will be received months, weeks, years?
Well at least it is a sale and it is a start but a lot more info is need to extrapolate gross and net income. imo
Andre
Speaking of "being a bit egotistical"
I took their answer to mean no competition like a High School basketball team is no competition to an NBA team. A bit cocky? yes
An obviously unfactual answer to a question? Remains to be seen...
IMO
Andre
Thanks numbers
I like the response to the last question!
"A: None really. They may think they are, but we don't consider their technology to be competition once word gets out."
PRICELESS!!!!!!
now lets make it happen
capitalism
If a company meets the criteria of more than $10 million and 500 shareholders is there some type of mechanism or a time frame which they must find a new exchang to trade on? tia
capitalism
If a company meets the criteria of more than $10 million and 500 shareholders is there some type of mechanism or a time frame which they must find a new exchang to trade on? tia
capitalism
If a company meets the criteria of more than $10 million and 500 shareholders is there some type of mechanism or a time frame which they must find a new exchang to trade on? tia
capitalism
If a company meets the criteria of more than $10 million and 500 shareholders is there some type of mechanism or a time frame which they must find a new exchang to trade on? tia
Threes
<<will be the ones to buy out NNLX >>>
Thats not happening Battelle will not be buying Nano nor will the TMC a hospital group. IMO
Andre
Is it just me or did the yahoo board change from nnlx.pk to just nnlx? It does not have a board.
Andre
I had nothing to say!! hahaha
After i posted it I wanted to reword it but I had to go to work.
I hadn't realized that viruses had been brough up that many times before. With the GBS trial near completion and the TMC most likely shifting to MRSA next and Battelle working on TB and six GRam neg and Gram pos. bacteria it only makes sense to get started om the next step (viruses) The third party (Batelle) is is doing the work for FDA approval so no sense in sitting around waiting.Anywaty just my thoughts!!!!!!
Happy Friday
Andre
The question is not how much he is costing the company but what is his worth?
if he figures out a method to detect viruses with the product that is quick and easy what do you think the value to the company will be?
Andre
TTBOY
With the addition of of this new guy maybe this is where we are headed. Look at his credentials.
<<<Phillip Vermilion
Senior Laboratory Technician
Phillip brings extensive microbiology expertise to NanoLogix, including vast experience working in a biosafety level 3 lab with security clearance. From 2004 - 2011, he served as a Technician Specialist with Battelle’s Biomedical Research Center (BBRC) division. There he concentrated on a wide array of bacterial and viral agents, as well as a large variety of immunological and bacteriological assays. Much of Phillip’s work at the BBRC involved culturing both viral and bacterial agents as well as performing validations and qualification procedures on assays and equipment.>>>
http://nanologix.com/about/team.html
A great addition to Nanologix!
Andre
ttboy
This is a reference to viruses in one of there patents (almost at the end of documenmt just before examples)
<<<Identification of single virus particles seems to be possible by the present invention (EIA version for single virus particle). Trapping of single virus particles in SDU could be realized by the usage of special filters such as membranes (ex. dialysis membrane), treating the inner walls of the micro-channels with specific antibodies, lectines or other reagents, or employment of magnetic particles.>>>
http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=2&f=G&l=50&co1=AND&d=PTXT&s1=nanologix&OS=nanologix
Andre
Nano
it refers to this poster with the added step(s)putting sample in a centrifuge.
http://nanologix.com/cms-assets/documents/54717-248038.nnlx-faro-poster-sgi-031812.pdf
Andre
The question is will we hear about this
<<<Food Safety
As it continues to explore other fields with market value, NanoLogix is developing its BNF product for early screening of a specific strain of Listeria. We are in the process of refining antibodies that should provide the ability to specifically differentiate the targeted strain from any others. This work is being done for a major food processing company in the United States>>>>
or this
<<< May 31, 2011
Based on the success of the ASM and other business building activities, the company will be shipping BNP and BNF kits to the USDA next week for testing and to a major food processing company in a few weeks.>>>
Rivers77
If NNLX continues with the patent of releasing new quick results for bacteria ever week and half with two per release as they have been doing that would be six new bacteria with rapid results before the food safty sumit. those six maybe
Streptococcus pyogenes,
Enterobacter cloacae
Klebsiella pneumoniae
Pseudomonas aeruginosa
Listeria spp
Escherichia coli (E.coli)
Those six were taken from the nnlx websit test result page sans the yeast and molds the only one which I did not include was MRSA which I feel will be released by a publication or PR from The Teaxas Medical Center. As far as the TB goes the fact that NNLX time to detection is 1 1/2 hrs is huge and maybe released to the masses via a PR or publication or even as someone (nanobuyer)suggested on the Yahoo board mybe on world TB day March 24th.
All the above is just spulation on my part I have no direct knowldge or communication with the company it is just my WAG!!
Andre
river77
Read my posts on the thread from the yahoo board. "connecting dots"
http://messages.finance.yahoo.com/Stocks_%28A_to_Z%29/Stocks_N/threadview?m=te&bn=73175&tid=56270&mid=56270&tof=32&frt=1#56270
I feel Battelle is selecting the bacteria to test. I also think that the MRSA sub 1 hr will come from TMC and it will be with a pr from the TMC or a publication maybe even with a paper released.
JMHO
Andre
river77
My gut told me Sept of 2011 so I don't listen it it anymore
I don't really know. What I do know however is these new test results are being released ever week and a half to two weeks it seems it has been given greater important now. My guess for the next bacteria to go sub 1hr is Burkholderia Mallei and Francisella Tularensis. Both can be used as biological weapons. If things stay at this pace expect next release by the weekend or by the 14th. Either way any new bacteria sub 1 hour is a great thing!!
Andre
River77 stated that he would like to see 1 or two 100k pops tomorrow. He was refering to a single transaction of 100k nowhere did he state per day.
<<<Reading comprehension is one of the most important skills to acquire in life. Very few people have been able to master it and this is one example that unfortunately could come at a very high price.>>>
I guess we all make mistakes!!!!!!!!!!!!!1